Background {#Sec1}
==========

Fluid resuscitation is the cornerstone of fluid management wherever in ICU or in perioperative period. Excessive volume expansion increases the risk of pulmonary edema, impairs the cardiac ventricular function, and even causes renal dysfunction \[[@CR1]\]. However, hypovolemia could also lead to oxygen deliver disorder in critical organs which poses a great threat to life \[[@CR2], [@CR3]\].

Different from adult patients, pediatric patients possess larger ratio of body surface area to weight and higher water quality. Physically, children's body compositions such as water proportion or muscle proportion are changing as they grow older, especially rapidly changing in preterm and term infants during the first 12 months of life \[[@CR4]\]. Moreover, the myocardial structure of the heart, particularly the volume of cellular mass devoted to contractility, is significantly less developed in neonates than in adults. These differences, as well as developmental changes in contractile proteins, produce a leftward displacement of the cardiac function curve and less compliant ventricles. This developmental immaturity of myocardial structures also accounts for the tendency toward bi-ventricular failure, sensitivity to volume loading, poor tolerance of increasing afterload, and heart rate-dependent cardiac output \[[@CR5], [@CR6]\]. Due to pediatric patients' special physical body structure, those deleterious effects caused by inappropriate fluid therapy should be taken more seriously in children. Therefore, physicians need to make a prompt and precise clinical decision in preloading judgment for children.

Considering special physical structure, it is hard to accurately assess children volume state in many situations. Clinically, many monitoring indices are applied to help physicians to assess fluid responsiveness. Traditional static indices, such as blood pressure (BP), central venous pressure (CVP), and pulmonary artery wedge pressure (PAWP), although are important but of limited sensitivity and specificity, especially in intra-abdominal hypertension, one lung ventilation, and prone position \[[@CR7]--[@CR9]\]. The famous Frank--Starling Law mandates that, in a certain range capability, the heart could adjust ventricular contractility and cardiac ejection to dynamic changes in ventricular filling \[[@CR10], [@CR11]\]. According to this, usually, a patient, who has the increment over 15% or 10% from baseline measurements in physiological parameters after volume expansion, is defined as fluid responsiveness positively \[[@CR12]--[@CR14]\]. Usually, indices which are directive to reflect cardiac ejection, such as stroke volume (SV), cardiac output (CO), cardiac index (CI), were seen as the gold standard indices to judge fluid responsiveness \[[@CR14]\]. However, the measurement of the gold standard indices needs invasive operation and expensive monitoring equipments although they are accurate. Over the last decade, hemodynamic parameters, such as stroke volume variation (SVV) or pulse pressure variation (PPV), were reported to have a strong capability to assess fluid responsiveness during ventilation \[[@CR15]--[@CR17]\]. These hemodynamic parameters are based on heart-lung interaction that, in the air-tight thoracic construction, mechanical ventilation introduces cyclic changes in preload, leading to matched cardiac ejection and pulse pressure variation \[[@CR18], [@CR19]\]. However, the expensive equipment and invasive procedure also restrict the widespread application of these parameters.

Recently, noninvasive dynamic indices that calculate variation of peak velocity of the artery during several respiratory cycles measured by ultrasound have become an alternative quick volume assessment method \[[@CR20], [@CR21]\]. However, vessels in pediatric patients are thinner and more variable than adults. These distinctions bring challenges to noninvasive ultrasonagraphic techniques in children. Among all the vessels, the aortic artery is the largest and the nearest vessel next to cardiac ejection and is feasible and available to access whenever in ICU or in operating room. A recent review has reported that only respiratory variation in aortic blood flow peak velocity (△VPeak) has the capability to predict fluid responsiveness in children rather than SVV or PPV \[[@CR22]\]. In 2015, a meta-analysis of 6 studies concluded that △VPeak showed good diagnostic accuracy in ventilated children \[[@CR23]\]. However, it failed to find the optimal △VPeak threshold and potential factors that influence the accuracy of △VPeak due to limited included studies.

Our research was conducted to estimate the diagnostic accuracy of △VPeak as a predictor of fluid responsiveness in ventilated children, explore the potential factors that influence the accuracy of △VPeak, and analyze the most accurate threshold of △VPeak to predict fluid responsiveness in ventilated children.

Methods {#Sec2}
=======

Study selection and inclusion criteria {#Sec3}
--------------------------------------

All diagnostic tests that study △VPeak as a predictor of fluid responsiveness of ventilated children were included in our research. The gold standard method of assessing fluid responsiveness was defined as an increase in CO, CI, SV, and stoke volume index (SVI) after volume expansion. And the sensitivity, specificity, and cutoff value of △VPeak to predict fluid responsiveness in ventilated children could be found or calculated in the original work.

Studies which did not clarify the patients' age, number and basic characteristics, original paper or effective data unavailable, spontaneously breathing patients, studies conducted in animals or experimental researches, reviews, and letters were excluded. No language restriction was applied. No ethical and patient consent was required.

Search strategy and data extraction {#Sec4}
-----------------------------------

Two authors searched relevant clinical studies on PubMed, Embase, and Cochrane from inception to April 2019, and then independently screened literature, extracted data, and evaluated quality. If discrepancy existed, it was solved by the third arbitration. The whole search strategy used free words including fluid, responsiveness, pediatric, children, infant, kid, child, aortic, peak, and variation, and we combined words or phrases freely once more to acquire thorough results.

All the search was implemented by two authors strictly under the protocol, both of them screened the title and abstract. Irrelevant papers were neglected, while relevant and directly related papers were searched for full text, and those studies that measured △VPeak as the secondary observational index rather than the main index or the only index might also be included. Non-English language research was looked for original resources. Extracted data included three parts: the first one was basic information about the research such as the number of patients and study year. The second and the most important part was the results of the gold standard index and study index, including the gold standard index and the assessment of fluid responsiveness, cutoff value, sensitivity, specificity, and the area under receiver operating characteristic curve (ROC) of △VPeak. According to the collected data, we calculated true positive, false positive, false negative, and true negative values to construct the 2 × 2 contingency table. The last one was discrepancy among studies that could be the heterogeneity or potential factors that influence △VPeak. We collected age, liquid sort, measuring tool, ventilation parameter, vasoactive drugs, and study places.

All included researches were needed to provide adequate information satisfying meta-analysis. If data was unclear in the original paper to form 2 × 2 contingency table or characteristic form, we sent emails to the corresponding author for clarifying. If the author failed to respond in 1 month, we excluded the study in the final analysis.

Quality assessment {#Sec5}
------------------

Included studies were assessed by the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) recommended by the Cochrane Handbook \[[@CR24], [@CR25]\]. The QUADAS-2 tool consists of four domains: patient selection, index test, reference standard, and flow and timing. All domains were evaluated in terms of risk of bias and would be answered as "yes," "no," and "unclear" according to the specific content of each domain. The risk could be defined as low under the circumstance of a consistency of "yes," and if all questions' answers were "yes" but only one was "no," the bias was possibly existing, and the author needs to judge the risk level according to the guidelines. "Unclear" was defined if the original study failed to provide adequate information that the authors had difficulty to judge. Quality assessment was performed by Revman software 5.3.

Statistical analysis {#Sec6}
--------------------

Data synthesis was performed within the bivariate mixed-effects regression model that could incorporate the negative correlation, which might arise between the sensitivity and specificity as a result of the different threshold value of △VPeak used in studies \[[@CR26], [@CR27]\]. We estimated overall pooling of sensitivity, specificity, and diagnostic odds ratio (DOR) with 95% confidence interval (CI) using a bivariate random-effects model. We also plotted summary receiver operating characteristic curve (SROC) and calculated the area under the summary receiver operating characteristic curve (AUSROC).

Scatter plot was conducted to observe the distribution, dispersion, central tendency, and extremum of △VPeak cutoff value in all included studies. Mean and median △VPeak cutoff values were also calculated. We finally combined the mean, median, and scatter plot to estimate the optimal △VPeak threshold value for the prediction of fluid responsiveness in ventilated children.

Heterogeneity was quantitatively assessed by using the chi-square test and Cochran's *Q* test. To describe the percentage of total attributed to heterogeneity rather than chance, we quantified the effect of heterogeneity using inconsistency (*I*^2^). *P* value for *Q* test \< 0.1 or *I*^2^ \> 50% were considered existing significant heterogeneity. Heterogeneity caused by the threshold effect in the diagnostic test was calculated in the Spearman correlation coefficient, which was estimated by the Moses--Shapiro--Littenberg \[[@CR28]\]. Meta-regression was conducted to explore the potential sources of heterogeneity among studies beyond the threshold effect. Age, gold standard indices, fluid types, and vasoactive drugs were considered as potential factors to discriminate subgroups.

Public bias was estimated by Deek's funnel plot asymmetry test, with *P* \< 0.1 indicating statistical significance \[[@CR29]\].

The results were expressed as mean (95%CI) or as mean ± standard deviation. Meta-analysis was performed by Stata 15. 0 (StataCorp, College Station, TX) with the Midas module. A two-tailed *P* \< 0.05 was considered statistically significant.

Results {#Sec7}
=======

Characteristic of studies {#Sec8}
-------------------------

Our meta-analysis yielded 540 studies after initially reviewed in three databases. Figure [1](#Fig1){ref-type="fig"} shows the PRISMA selection of this meta-analysis. A total of 203 studies were removed due to duplicates. In the remaining 337 studies, 316 were excluded because of patients not eligible for the study purpose, abstract unavailable, reviews or letters, and animal researches. Further screening the full article, 10 full texts were excluded due to incomplete outcomes, unclearly included standard, and unqualified method of measuring △VPeak. Finally, 11 studies with a total of 302 pediatric patients were included in our meta-analysis \[[@CR30]--[@CR40]\]. Fig. 1Flowchart of the study selection. △VPeak, respiratory variation of aortic peak velocity

Characteristics of the included studied are summarized in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}. A total of 161 children patients were responders (53.3%) to fluid challenge. The cutoff value of △VPeak varied from 7 to 20%. Ten studies were performed before, during, or after cardiac surgery (*n* = 4) or neurosurgery (*n* = 3), and two of them took measurement time point after arriving at ICU for 30 min \[[@CR35]\] and 1 h \[[@CR31]\]. However, only one study \[[@CR30]\] was performed in ICU with mixed diseases in critically ill children. Four studies referred △SV \> 15%, and five studies referred △SVI \> 15% as the gold standard index of responders to fluid challenge. Except Favia et al. \[[@CR38]\], all other included studies were prospective diagnostic tests, and the gold standard index in this study was measured by peripheral artery wave contour analysis monitor rather than ultrasound. △VPeak in the total 11 studies was all performed with transthoracic echocardiography (*n* = 7) or transoesophageal echocardiography (*n* = 4). Table 1Selected characteristics of the included studiesNo.Authors/yearSample sizeAge (months)Settings or time point of measureVEGolden index (responders)Tool measuring golden indexTool measuring △VPeakTide volume (ml/kg)PEEP (cmH~2~O)Vasoactive drugs1Durand 200826*M* = 28.5ICU20 ml /kg/6%HES or saline 15--30 min△SV \> 15%TTETTE7.44Yes2Choi 201021*A* = 30VSD repair, 1 h after arriving at ICU10 ml/ kg/6%HES over 20 min△SV \> 15%TTETTE100Yes3Renner 201127*A* = 17Before cardiac surgery begin10 ml/ kg/6%HES△SVI \> 15%TOETOE103--5Yes4Pereira 201130*A* = 112Before neurosurgery incision20 ml /kg/saline over 15 min△VTI \> 15%TTETTE100--2Yes5Byon 201333*A* = 72.1Stable during neurosurgery10 ml/ kg/6%HES 10 min△SVI \> 10%TTETTE100UC6Lee 201426*A* = 28VSD repair, 30 min after arriving at ICU10 ml/ kg/6%HES 20 min△SV \> 15%TTETTE105Yes7Lee 201529*A* = 13.7Once sternum closed after VSD repair10 ml/ kg/6%HES 10 min△SVI \> 15%TOETOE10UCYes8Krishna 201642*A* = 76General endotracheal anesthesia10 ml/ kg/1%DRL 5-10 min△SVI ≥ 15%TTETTE100UC9Favia 201716*A* = 24.2Sternal closure in cardiac surgery10 ml /kg/crystalloid or blood products△CI \> 10%MostCare™TOE8--100--10No10Lee 201730*A* = 19.2After cardiac surgery end before entering ICU10 ml/ kg/6%HES 20 min△SVI \> 15%TOETOE10UCYes11Morparia 201822*A*==69.8Neurosurgery10 ml/ kg/crystalloid△SV \> 15%TTETTE8--100--4sNO*A* average age, *min* minute, *M* median age, *VE* volume experiment, *HES* hydroxyethe1 starch, *DRL* dextrose Ringer's lactate, *△VPeak* respiratory variation of aortic peak velocity, *VSD* ventricular septal defect, *PEEP* positive end-expiratory pressure, *UC* unclear, *SV* stroke volume, *SVI* stroke volume index, *VTI* velocity-time integral, *TTE* transthoracic echocardiography, *TOE* transoesophageal echocardiography Table 2Diagnostic performance of pulse pressure variation from included studiesNo.Authors/yearThreshold^a^ (%)TPFPFNTNSens (%)Spec (%)AUROCResponders (%)1Durand 2008121513781.285.70.8569.232Choi 2010201011991900.8352.383Renner 20117132012100850.9248.154Pereira 2011101700131001001.056.675Byon 20131113521386.772.20.80445.456Lee 20141412211192.085.00.95650.007Lee 201513.59341369.278.60.7744.838Krishna 201612.2241017100940.97557.149Favia 201716.5641583.055.00.7043.7510Lee 20171210271158.884.60.76556.6711Morparia 201812.31013877890.9059.09*TP* true positive, *FP* false positive, *FN* false negative, *TN* true negative, *Sens* sensitivity, *Spec* specificity, *AUROC* area under the receive operator characteristic curve, *Threshold*^*a*^ threshold used in studies to achieve corresponding sensitivity and specialty, *95%CI* 95% confidence interval

Methodological quality of studies {#Sec9}
---------------------------------

All included studies met patient spectrum criteria, had acceptable delays between index and reference tests, and performed the index and reference test in all included patients. One study used MostCare™ monitor to measure CI as a reference standard. Overall, the included studies were poorly reported in terms of blindness between index and reference tests, and most studies clarified uninterpretable tests unclearly. Table [3](#Tab3){ref-type="table"} and Fig. [2](#Fig2){ref-type="fig"} show the methodological quality of the included studies, which was assessed by QUADAS2. Table 3Quality assessment of included studies using QUADAS-2 domainsAuthor/yearRisk of biasApplicability concernsPatient selectionIndex testReference standardFlow and timingPatient selectionIndex testReference standardDurand 2008☹?☺☺☺☺☺Choi 2010☺?☺☺☺☺☺Renner 2011☺☺☺☺☹☺☺Pereira 2011☺☺☺☺☺☺☺Byon 2013☺?☺☺☺☺☺Lee 2014☺???☺☺☺Lee 2015☺???☺☺☺Krishna 2016☺?☺???☺Favia 2017☺?☹?☺☺☺Lee 2017☺?☺☺☺☺☺Morparia 2018☺?☺☺☺☺☺☺ low risk, ☹ high risk, ? unclear risk Fig. 2Sensitivity and specificity of respiratory variation of aortic peak velocity for prediction of fluid responsiveness in ventilated children for all data. CI, confidence interval

Prediction of fluid responsiveness based on △VPeak {#Sec10}
--------------------------------------------------

Pooled sensitivity of △VPeak was 0.89 (95%CI 0.77 to 0.95), and pooled specificity of △VPeak was 0.85 (95%CI 0.77 to 0.91), presented in Fig. [3](#Fig3){ref-type="fig"}. The positive and negative likelihood ratio of △VPeak was 5.9 (95%CI 3.6 to 9.7) and 0.12 (95%CI 0.05 to 0.29), respectively. The diagnostic odds ratio (DOR) of △VPeak was 48 (95%CI 15 to 155). SROC yielded an area under the curve of 0.91 (95%CI 0.88--0.93), presented in Fig. [4](#Fig4){ref-type="fig"}. Fig. 3Risk of bias and applicability concerns for the studies included in the meta-analysis. **a** Risk-of-bias summary. **b** Risk-of-bias graph Fig. 4Summary receiver operating characteristic curve of respiratory variation of aortic peak velocity for predicting fluid responsiveness. Each circle represents individual study estimates. The diamond is the summary point representing the average sensitivity and specificity estimates. AUC, area under the curve; SENS, sensitivity; SPEC, specificity; SROC, summary receiver operating characteristics. The ellipses around this summary point are the 95% confidence region (dashed line) and the 95% prediction region (dotted line)

The assessment optimal △VPeak threshold value to predict fluid responsiveness in ventilated children {#Sec11}
----------------------------------------------------------------------------------------------------

The △VPeak cutoff value in each included studies is presented in a scatter plot shown in Fig. [5](#Fig5){ref-type="fig"}. In Fig. [5](#Fig5){ref-type="fig"}, the △VPeak cutoff values were nearly conically symmetrical distribution, varied from 7 to 20%, and excluding several extreme studies, most data were centered between 12 and 13%. The mean △VPeak cutoff value was 12.7%, with the deviation of 0.03. The medium △VPeak cutoff value was 12.2%. Fig. 5Scatter plot of cutoff value of respiratory variation of aortic peak velocity in included studies. The cutoff values of included studies are as follows: (1) Durand 2008 \[[@CR30]\], 12%; (2) Choi 2010 \[[@CR31]\], 20%; (3) Renner 2011 \[[@CR32]\], 7%; (4) Pereira 2011 \[[@CR33]\], 10%; (5) Byon 2013 \[[@CR34]\], 11%; (6) Lee 2014 \[[@CR35]\], 14%; (7) Lee 2015 \[[@CR36]\], 13.5%; (8) Krishna 2016 \[[@CR37]\], 12.2%; (9) Favia 2017 \[[@CR38]\], 16.5%; (10) Lee 2017 \[[@CR39]\], 12%; (11) Morparia 2018 \[[@CR40]\], 12.3%

Heterogeneity investigation {#Sec12}
---------------------------

Heterogeneity of these studies was assessed with Cochran's *Q* of 1.98 and overall *I*^2^ statistic of 0%. No significant heterogeneity was found for specificity, DOR, and positive and negative likelihood ratio. However, *I*^2^ statistic of sensitivity was 62.23% and Cochran's *Q* of it was 26.27. The cutoff value of △VPeak varied from 7 to 20%, which could cause threshold effect heterogeneity. The Spearman correlation coefficient was 1, indicating that the proportion of heterogeneity likely due to the threshold effect was 100%. As a result, meta-regression was unnecessary.

Subgroup analysis {#Sec13}
-----------------

In subgroup analysis, we found that △VPeak performed weak in the younger children group, with the area under the curve of ROC of only 0.77, 0.70, and 0.765 in mean age of 13.7 months \[[@CR36]\], 24.2 months \[[@CR38]\], and 19.2 months \[[@CR39]\], respectively. Compared to the total data, the younger children group (mean ages \< 25 months) had lower AUSROC of 0.80 (0.76 to 0.83). However, △VPeak performed a stronger ability of prediction in the older children group (mean ages \> 25 months), with AUSROC of 0.96 (0.94 to 0.97), presented in Table [4](#Tab4){ref-type="table"} and Fig. [6](#Fig6){ref-type="fig"}. Besides, the prediction accuracy of △VPeak was not affected by the gold standard index, vasoactive drugs, and fluid types (see Additional file [1](#MOESM1){ref-type="media"}). Table 4Diagnostic accuracy of △VPeak in the group of agesAges (mean)NumbersSensitivitySpecificityDiagnostic odds ratioSROC (95%CI)All patients110.89 (0.77--0.95)0.85 (0.77--0.91)48 (15--155)0.91 (0.88--0.93)\< 25 months40.81 (0.54--0.94)0.79 (0.66--0.88)16 (4--64)0.80 (0.76--0.83)≥ 25 months70.92 (0.82--0.97)0.89 (0.77--0.95)91 (21--385)0.96 (0.94--0.97) Fig. 6Summary receiver operating characteristics curve of respiratory variation of aortic peak velocity for the prediction of fluid responsiveness in **a** mean age of ventilated children \< 25 months and **b** mean age of ventilated children ≥ 25 months. Circles represent each study included in the meta-analysis. AUC, area under the curve; SENS, sensitivity; SPEC, specificity; SROC, summary receiver operating characteristics

Public bias {#Sec14}
-----------

Deek's funnel plot asymmetry test of △VPeak is shown in Fig. [7](#Fig7){ref-type="fig"}, and no significant public bias was found in our meta-analysis (*P* = 0.12). Fig. 7Deeks' funnel plot with superimposed regression line. *P* value for slope coefficient is 0.12, which is greater than 0.05, suggesting the symmetry of the studies and the low likelihood of publication bias

Discussion {#Sec15}
==========

Our systematic review and meta-analysis found that overall, △VPeak performed well in predicting fluid responsiveness of ventilated children, with pooled sensitivity of 0.85, pooled specificity of 0.89, and AUSROC of 0.91. We synthesized the mean, median, and scatter plot to estimate that the most accurate value of △VPeak for prediction of fluid responsiveness in ventilated children is reliable between 12 and 13%. However, the accuracy of △VPeak decreased in children less than 25 months.

As we all know, each cardiac contraction brings a stroke volume from the left ventricle, and the blood flow passes through the vessel tract at different speed depending on the amount of blood ejection, the diameter of the tract, and blood velocity. In fact, △VPeak measured by ultrasound is similar to SVV, but it transforms invisible stroke volume to digital speed as an alternation. According to Rudnick's theory, the closer the measurement position to cardiac ejection, the more accurate the prediction for hemodynamic indices to reflect central perfusion \[[@CR41]\]. In our study, △VPeak showed a strong ability to predict fluid responsiveness in ventilated children, with AUSROC more than 0.9 and high sensitivity and specificity.

Desgranges et al. \[[@CR23]\] first performed a six study systematic review and meta-analysis, but it failed to find optimal threshold value for △VPeak to predict fluid responsiveness in ventilated children due to extent variation of △VPeak cutoff value and inadequate data. However, more studies were published in the recent years, and comparing with demonstrating △VPeak is capable for predicting fluid responsiveness of ventilated children, acquiring optimal △VPeak threshold value of prediction possesses more clinical value. In a similar meta-analysis of respiratory variation in inferior vena cava diameter (△IVC), Si et al. \[[@CR42]\] directly calculated the mean cutoff value of △IVC with only six studies in subgroups as the optimal threshold value of △IVC. In our scatter pot of △VPeak cutoff value, we observed that the cutoff value of △VPeak distributed symmetrically around the value of 12 to 13% \[[@CR43]\]. And excluding several extreme studies, most data were centered between 12 and 13%. Combining mean and medium values, we estimated the most accurate value of △VPeak for prediction of fluid responsiveness in ventilated children is between 12 and 13%.

The extreme △VPeak cutoff values in our systematic review were 7% and 20%. Renner \[[@CR32]\] performed volume expansion and △VPeak measurement after induction of anesthesia and before surgery. Without any fluid loss and hemodynamic alteration induced by surgery, such as trauma \[[@CR44]\] and incision evaporation, patients possessed a stable volume state, and we observed a smaller value of △VPeak in Renner's study than in other included studies, with 10.1% and 5.2% separately in responsive and non-responsive group before fluid loading, which could be the reason for only 7% cutoff value of △VPeak. Besides, fluid time is defined as the time of fast volume expansion with colloid 400--600 ml or crystalloid 300--1000 ml, usually within 30 min \[[@CR45]\], while Renner's study did not clarify fluid time of volume expansion. Recent evidence indicated that fluid responsive proportion decreased as fluid time extended \[[@CR14]\], which could be a mixed factor for the cutoff value of △VPeak in Renner's study. In another extreme condition, Choi et al. \[[@CR31]\] got a 20% cutoff value for △VPeak. Compared to other included studies, Choi chose 1 h after arriving at ICU as measurement time point in cardiac surgery children. However, not only blood loss caused absolute inadequate volume state, trauma and stress could also rise plant nerve disorder, leading to relative hypovolemia \[[@CR46], [@CR47]\]. What is more, 1-h treatment in ICU may also increase variations in the hemodynamic state. Evidence shows that postoperative hemorrhage is a frequent complication after cardiac surgery \[[@CR48]\], and patients after cardiac surgery represent a challenging high-risk population with specific requirements in catecholamine and fluid therapy in face of compromised cardiac performance and pronounced systemic inflammatory response after cardiopulmonary bypass \[[@CR49]\]. Considering reasons above, patients were in high degree hypovolemia state before volume expansion, and we indeed observed a larger value of △VPeak in both groups, which could finally rise for large cutoff value of △VPeak.

In a subgroup analysis, compared to total data analysis, the prediction accuracy of △VPeak decreased in the younger age group (mean age \< 25 months) and increased in the older age group (mean age \> 25 months), indicating that clinicians should be cautious to apply △VPeak in younger children, especially children under 25 months, which was not mentioned in the previous study. Compared to Desgranges et al. \[[@CR23]\], studies that gave a lower area under the curve of ROC (less than 0.8) emerged only in new studies published in recent years, and we have reasons to believe age is a potential factor to predictive accuracy of △VPeak. We consider inaccurate prediction of △VPeak could be relative to anatomical variation in younger children due to distinctive development, especially in children with congenital heart defects \[[@CR50]\]. Studies reported that cardiac function in the immature left ventricle might be characterized by a higher basal contractile state, reduced compliance, and greater sensitivity to changes in afterload \[[@CR51]--[@CR53]\]. Moreover, Wolf et al. \[[@CR53]\] found the neonatal myocardium is less responsive to preload and is vulnerable to overfilling. Due to limited data in different months phase, we failed to conclude the exact age group that optimally suitable for △VPeak. But children more than 3 years old could be more reliable on clinical work because of mature organs of the heart and vessels. With respect to the measurement tool of △VPeak, we are interested to find all younger group studies included in our research measured △VPeak by transthoracic or transoesophageal echocardiography. So far, no direct evidences have shown the distinction between transthoracic and transoesophageal echocardiography or the two methods could substitute for each other, but the closer measurement position to cardiac ejection, the more accurate to reflect central perfusion \[[@CR41]\], and the two measurement methods both take close position to cardiac ejection. We concluded transoesophageal echocardiography had similar or slightly higher accuracy. Vasoactive drugs could activate α and β receptors in the heart and vessels, augment heart rate, and increase cardiac afterload, which could influence volume state and velocity of cardiac ejection. However, Sakai et al. \[[@CR54]\] examined the effects of adrenaline administration on changes in circulatory dynamics and cardiac function in rats pretreated with chlorpromazine, and consequently found SV did not change significantly, and SVV significantly reduced at 1 and 2 min after treatment with adrenaline, but returned back to baseline thereafter. In our study, seven included studies used vasoactive drugs, and the vasoactive group yielded an area under SROC of 0.92, which was similar to total data, indicating vasoactive drugs had no significant impact on △VPeak.

In our study, overall data Cochran's *Q* and *I*^2^ statistical analysis shown no significant heterogeneity, but significant heterogeneity for sensitivity existed and we still cannot rule out any potential heterogeneity. The threshold effect is one of the main causes of heterogeneity in diagnostic tests due to different cutoff values used in different studies to determine a positive (or negative) result. The Spearman correlation coefficient value in our study was 1, which meant the heterogeneity could be fully explained by the threshold effect \[[@CR55], [@CR56]\], which has not been explained in Desgranges' study \[[@CR23]\].

There are some limitations in our study. Firstly, sample size and study numbers in our meta-analysis were limited, although they were twice the number than previous studies. We included 11 diagnostic tests distributed between 2008 and 2018, with only 302 sample sizes, which were much smaller than the similar scale meta-analysis \[[@CR42]\]. We attributed this phenomenon to the fact that ventilated children requiring △VPeak measurement were most critical or severe trauma, such as cardiac surgery, neurosurgery, or complicated diseases hospitalized in ICU. This population was rather small and each clinical study included in our meta-analysis collected limited samples. However, even under this condition, a meta-analysis still provided valuable information on the diagnostic accuracy until proven by larger or better-conducted studies \[[@CR57]\]. Secondly, time of volume expansion was different or not clarified in our included studies. In the recent years, Toscani and colleagues \[[@CR14]\] conducted a large sample meta-analysis finding that responsive proportion of population had no significant correlation with the type and volume of fluid but decreased with long infusion time, especially more than 30 min. Although most included studies in our meta-analysis restricted infusion time less than 20 min, we still could not exclude infusion time as a factor for △VPeak accuracy. Thirdly, except Favia et al. \[[@CR38]\] using the peripheral artery wave contour analysis technique, the gold standard index was measured by transthoracic or transoesophageal echocardiography. To our knowledge, the closer measurement position to cardiac ejection, the more accurate prediction for hemodynamic indices to reflect central perfusion \[[@CR41]\]. However, we failed to find difference after excluding Favia's study (see Additional file [2](#MOESM2){ref-type="media"}), but we still could not rule out reference index measurement as a potential factor that influence accuracy of △VPeak, and more studies in the future could bring different results. Fourthly, included studies picked different time to start fluid challenge and △VPeak measurement, such as after anesthesia, during surgery, sternum closure, or even arriving at ICU. However, complicated operating procedure could rise variable hemodynamic state in different measurement points, which could not be neglected to our meta-analysis. Lastly, in subgroup analysis, we found age was a factor that influenced △VPeak accuracy. However, due to included studies providing a mean value of age rather than a limited scale of age, we only found a decline tendency of prediction accuracy of △VPeak rather than giving an accurate value of age that △VPeak should be recommended applied in. Therefore, more new studies are needed to be done in the future.

Conclusions {#Sec16}
===========

Overall, △VPeak has a good ability in predicting fluid responsiveness of children receiving mechanical ventilation and the optimal threshold value of △VPeak to predict fluid responsiveness is reliable between 12 and 13%. However, we observed that this ability decreased in younger children, especially mean age less than 25 months; thus, we expect more studies to make a statistic treatment in the future.

Supplementary information
=========================

 {#Sec17}

**Additional file 1.**Subgroup analysis of the gold standard index, vasoactive drugs and fluid types. **Table S1.** Subgroup analysis of the gold standard index, vasoactive drugs and type of drugs. **Figure S1.** Summary receiver operating characteristics curve of respiratory variation of aortic peak velocity for the prediction of fluid responsiveness in subgroups of gold standard index, fluid types and vasoactive drugs. **Additional file 2.**Excluded one retrospective study 's meta-analysis. **Figure S2**. Summary receiver operating characteristics curve of respiratory variations of aortic peak velocity for predicting fluid responsiveness in the left 10 studies (excluding Favia's study \[[@CR38]\]).
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